CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

PR Newswire Clinical Trials
Original article

Response Media launches RE:HEALTH to Address Pharma's $300 Billion Adherence Blind Spot¹

Positive
AI Analysis

Summary

Response Media launched RE:HEALTH, a new health and life sciences practice, and introduced AdherenceIQ, an AI-powered platform designed to predict patient adherence risk. The initiative addresses the estimated $300 billion annual cost of medication nonadherence in the U.S. healthcare system.

Importance:3/10
Sentiment:
0.50
patient_adherenceAI_platformhealthcare_costsmedication_nonadherence
Related Companies

Read the original article

Published by PR Newswire Clinical Trials on September 10, 2026 2:38 PM

Read Original